한글목차

Allied Market Research가 발행한 새로운 보고서 mHealth 시장에 따르면 mHealth 시장은 2022년 707억 달러로 평가되었으며, 2023년부터 2032년까지 18%의 CAGR로 성장할 것으로 예상됩니다. 2032년에는 3,707억 달러에 달할 것으로 추정됩니다.

모바일 헬스(mHealth)는 의료 및 공중 보건 관행을 지원하기 위해 의료에서 스마트폰, 태블릿과 같은 모바일 기기를 사용하는 것으로 정의되며, mHealth는 주로 당뇨병, 고혈압, 심장병과 같은 여러 급성 및 만성 질환의 모니터링 및 치료에 전개되는 무선 기술의 사용을 포함합니다.

세계 mHealth 시장의 성장을 가속하는 주요 요인으로는 의료기기의 급속한 기술 발전, 만성 심장병 환자 증가, 심장병 환자를 모니터링하기 위한 mHealth 기기에 대한 수요를 더욱 증가시키는 당뇨병 유병률 증가 등이 있습니다. 예를 들어, 미국 질병예방통제센터(CDC)의 2022년에 따르면 2020년 미국에서는 약 697,000명이 심장병으로 사망할 것으로 예상됩니다. 또한 미국 국립보건통계센터(National Center for Health Statistics 2022)에 따르면, 20초마다 1명의 미국인이 심장마비를 앓고 있습니다. 따라서 매년 100만 명 이상의 미국인이 심장마비를 앓고 있는 셈입니다.

그러나 규제 준수 확보에 대한 우려가 mHealth 시장의 성장을 제한할 것으로 예상됩니다. 반면, 신흥국의 의료비 지출 급증과 더 나은 치료 옵션에 대한 미충족 의료 수요는 향후 세계 시장 확대에 유리한 기회를 창출할 것으로 예상됩니다.

목차

제1장 서론

제2장 주요 요약

제3장 시장 개요

• 시장 정의와 범위
• 주요 조사 결과
  • 영향요인
  • 주요 투자 기회
• Porter의 Five Forces 분석
• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
• 시장에 대한 COVID-19의 영향 분석

제4장 모바일 헬스 시장 : 유형별

• 개요
• 모바일 헬스 디바이스
  • 모바일 헬스 기기 디바이스 유형별 모바일 헬스 시장
• 모바일 헬스 서비스
  • 모바일 헬스 서비스 서비스 유형별 모바일 헬스 시장

제5장 모바일 헬스 시장 : 용도별

• 개요
• 심혈관
• 당뇨병
• 호흡기
• 신경
• 기타

제6장 모바일 헬스 시장 : 이해관계자별

• 사업 개요
• 모바일 사업자
• 단말기 벤더
• 의료 제공자
• 애플리케이션 및 컨텐츠 사업자

제7장 모바일 헬스 시장 : 지역별

• 개요
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인
  • 기타
• 아시아태평양
  • 일본
  • 중국
  • 호주
  • 인도
  • 한국
  • 기타
• 라틴아메리카/중동 및 아프리카
  • 브라질
  • 사우디아라비아
  • 남아프리카공화국
  • 기타

제8장 경쟁 구도

• 서론
• 주요 성공 전략
• 주요 10개 기업의 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝, 2022년

제9장 기업 개요

• Boston Scientific Corporation
• DexCom, Inc.
• Fitbit
• Koninklijke Philips N.V.
• Medtronic plc
• Omada Health
• Omron Corporation.
• 남미 SUNG ELECTRONICS CO., LTD.
• Welldoc, Inc
• Teladoc Health, Inc.

영문목차

According to a new report published by Allied Market Research, titled, "mHealth Market," The mhealth market was valued at $70.7 billion in 2022, and is estimated to reach $370.7 billion by 2032, growing at a CAGR of 18% from 2023 to 2032. Mobile health (mHealth) is defined as the use of mobile devices, such as smartphones and tablets, in healthcare to support medical and public health practice. mHealth majorly involves the use of wireless technologies, which are deployed in monitoring and treatment of several acute and chronic disorders such as diabetes, hypertension, heart diseases, and others.

Major factors that drive the growth of the global mHealth market include rapid technological advancements in medical devices, increase in the number of patients suffering from chronic heart diseases, which further increase the demand for mHealth devices for monitoring heart disease patients, and rise in prevalence of diabetes. For instance, according to the Centers for Disease Control and Prevention (CDC) 2022, about 697,000 people in the U.S died from heart disease in 2020. In addition, according to a National Center for Health Statistics 2022, in every 20 seconds one American suffers a heart attack. Thus, more than 1 million Americans have a heart attack each year.

However, concerns related to ensuring regulatory compliance are expected to restrict the growth of the mHealth market. On the contrary, surge in healthcare expenditure and unmet medical demands to get better treatment options in developing countries are expected to create lucrative opportunities for the expansion of the global market in the future.

The mHealth market is segmented on the basis of type, application, stakeholder, and region. On the basis of type, the market is classified into mHealth devices and mHealth services. The mHealth devices segment is further categorized into blood glucose meter, blood pressure monitors, pulse oximetry, neurological monitors, cardiac monitors, apnea & sleep monitors, wearable fitness sensor device & heart rate meters, and others. The mHealth service segment is further categorized into prevention services, diagnostic services, monitoring services, treatment services, and wellness & healthcare system strengthening solutions. By application, the mHealth market classified into cardiovascular, diabetes, respiratory, neurology, and others. By stakeholder, the mHealth market is divided into mobile operators, device vendors, healthcare providers, and application & content players. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

The major players profiled in the report are Boston Scientific Corporation, DexCom, Inc., FITBIT, INC. (Google), Koninklijke Philips N.V., Medtronic plc, Omada Health, Omron Corporation, SAMSUNG ELECTRONICS CO., LTD., Teladoc Health, Inc., and Welldoc, Inc. These major players have adopted product approval, agreement, acquisition, collaboration, merger, and product launch as key developmental strategies to improve the product portfolio of the mHealth market.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the mhealth market analysis from 2022 to 2032 to identify the prevailing mhealth market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the mhealth market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global mhealth market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 20% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline talk to the sales executive to know more)

• Market share analysis of players by products/segments
• New Product Development/ Product Matrix of Key Players
• Average Selling Price Analysis / Price Point Analysis
• Criss-cross segment analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• Key player details (including location, contact details, supplier/vendor network etc. in excel format)
• SWOT Analysis

Key Market Segments

By Type

• mHealth Devices
  • Device Type
  • Blood Glucose Monitors
  • Blood Pressure Monitors
  • Pulse Oximetry
  • Neurological Monitors
  • Cardiac Monitors
  • Apnea and Sleep Monitors
  • Wearable Fitness Sensor Devices and Heart Rate Meters
  • Others
• mHealth Services
  • Service Type
  • Prevention Services
  • Diagnostic Services
  • Monitoring Services
  • Treatment Services
  • Wellness and Healthcare System Strengthening Solutions

By Application

• Cardiovascular
• Diabetes
• Respiratory
• Neurology
• Others

By Stakeholders

• Mobile operator
• Device Vendors
• Healthcare Providers
• Application and Content Players

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players:

• Boston Scientific Corporation
• DexCom, Inc.
• Fitbit
• Koninklijke Philips N.V.
• Medtronic plc
• Omada Health
• Omron Corporation.
• SAMSUNG ELECTRONICS CO., LTD.
• Teladoc Health, Inc.
• Welldoc, Inc

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key market segments
• 1.3. Key benefits to the stakeholders
• 1.4. Research Methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter's five forces analysis
  • 3.3.1. Low bargaining power of suppliers
  • 3.3.2. Low threat of new entrants
  • 3.3.3. Low threat of substitutes
  • 3.3.4. Low intensity of rivalry
  • 3.3.5. Low bargaining power of buyers
• 3.4. Market dynamics
  • 3.4.1. Drivers
    • 3.4.1.1. Rise in prevalence of cardiac diseases
    • 3.4.1.2. Increase in the incidence rate of diabetes
    • 3.4.1.3. Increase in demand for mHealth and wearable devices

• 3.4.2. Restraints
  • 3.4.2.1. Concerns related to ensuring regulatory compliance

• 3.4.3. Opportunities
  • 3.4.3.1. High growth potential in developing countries
  • 3.4.3.2. Rise in geriatric population

• 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: MHEALTH MARKET, BY TYPE

• 4.1. Overview
  • 4.1.1. Market size and forecast
• 4.2. mHealth Devices
  • 4.2.1. Key market trends, growth factors and opportunities
  • 4.2.2. Market size and forecast, by region
  • 4.2.3. Market share analysis by country
  • 4.2.4. mHealth Devices mHealth Market by Device Type
• 4.3. mHealth Services
  • 4.3.1. Key market trends, growth factors and opportunities
  • 4.3.2. Market size and forecast, by region
  • 4.3.3. Market share analysis by country
  • 4.3.4. mHealth Services mHealth Market by Service Type

CHAPTER 5: MHEALTH MARKET, BY APPLICATION

• 5.1. Overview
  • 5.1.1. Market size and forecast
• 5.2. Cardiovascular
  • 5.2.1. Key market trends, growth factors and opportunities
  • 5.2.2. Market size and forecast, by region
  • 5.2.3. Market share analysis by country
• 5.3. Diabetes
  • 5.3.1. Key market trends, growth factors and opportunities
  • 5.3.2. Market size and forecast, by region
  • 5.3.3. Market share analysis by country
• 5.4. Respiratory
  • 5.4.1. Key market trends, growth factors and opportunities
  • 5.4.2. Market size and forecast, by region
  • 5.4.3. Market share analysis by country
• 5.5. Neurology
  • 5.5.1. Key market trends, growth factors and opportunities
  • 5.5.2. Market size and forecast, by region
  • 5.5.3. Market share analysis by country
• 5.6. Others
  • 5.6.1. Key market trends, growth factors and opportunities
  • 5.6.2. Market size and forecast, by region
  • 5.6.3. Market share analysis by country

CHAPTER 6: MHEALTH MARKET, BY STAKEHOLDERS

• 6.1. Overview
  • 6.1.1. Market size and forecast
• 6.2. Mobile operator
  • 6.2.1. Key market trends, growth factors and opportunities
  • 6.2.2. Market size and forecast, by region
  • 6.2.3. Market share analysis by country
• 6.3. Device Vendors
  • 6.3.1. Key market trends, growth factors and opportunities
  • 6.3.2. Market size and forecast, by region
  • 6.3.3. Market share analysis by country
• 6.4. Healthcare Providers
  • 6.4.1. Key market trends, growth factors and opportunities
  • 6.4.2. Market size and forecast, by region
  • 6.4.3. Market share analysis by country
• 6.5. Application and Content Players
  • 6.5.1. Key market trends, growth factors and opportunities
  • 6.5.2. Market size and forecast, by region
  • 6.5.3. Market share analysis by country

CHAPTER 7: MHEALTH MARKET, BY REGION

• 7.1. Overview
  • 7.1.1. Market size and forecast By Region
• 7.2. North America
  • 7.2.1. Key trends and opportunities
  • 7.2.2. Market size and forecast, by Type
  • 7.2.3. Market size and forecast, by Application
  • 7.2.4. Market size and forecast, by Stakeholders
  • 7.2.5. Market size and forecast, by country
    • 7.2.5.1. U.S.
    • 7.2.5.1.1. Key market trends, growth factors and opportunities
    • 7.2.5.1.2. Market size and forecast, by Type
    • 7.2.5.1.3. Market size and forecast, by Application
    • 7.2.5.1.4. Market size and forecast, by Stakeholders
    • 7.2.5.2. Canada
    • 7.2.5.2.1. Key market trends, growth factors and opportunities
    • 7.2.5.2.2. Market size and forecast, by Type
    • 7.2.5.2.3. Market size and forecast, by Application
    • 7.2.5.2.4. Market size and forecast, by Stakeholders
    • 7.2.5.3. Mexico
    • 7.2.5.3.1. Key market trends, growth factors and opportunities
    • 7.2.5.3.2. Market size and forecast, by Type
    • 7.2.5.3.3. Market size and forecast, by Application
    • 7.2.5.3.4. Market size and forecast, by Stakeholders
• 7.3. Europe
  • 7.3.1. Key trends and opportunities
  • 7.3.2. Market size and forecast, by Type
  • 7.3.3. Market size and forecast, by Application
  • 7.3.4. Market size and forecast, by Stakeholders
  • 7.3.5. Market size and forecast, by country
    • 7.3.5.1. Germany
    • 7.3.5.1.1. Key market trends, growth factors and opportunities
    • 7.3.5.1.2. Market size and forecast, by Type
    • 7.3.5.1.3. Market size and forecast, by Application
    • 7.3.5.1.4. Market size and forecast, by Stakeholders
    • 7.3.5.2. France
    • 7.3.5.2.1. Key market trends, growth factors and opportunities
    • 7.3.5.2.2. Market size and forecast, by Type
    • 7.3.5.2.3. Market size and forecast, by Application
    • 7.3.5.2.4. Market size and forecast, by Stakeholders
    • 7.3.5.3. UK
    • 7.3.5.3.1. Key market trends, growth factors and opportunities
    • 7.3.5.3.2. Market size and forecast, by Type
    • 7.3.5.3.3. Market size and forecast, by Application
    • 7.3.5.3.4. Market size and forecast, by Stakeholders
    • 7.3.5.4. Italy
    • 7.3.5.4.1. Key market trends, growth factors and opportunities
    • 7.3.5.4.2. Market size and forecast, by Type
    • 7.3.5.4.3. Market size and forecast, by Application
    • 7.3.5.4.4. Market size and forecast, by Stakeholders
    • 7.3.5.5. Spain
    • 7.3.5.5.1. Key market trends, growth factors and opportunities
    • 7.3.5.5.2. Market size and forecast, by Type
    • 7.3.5.5.3. Market size and forecast, by Application
    • 7.3.5.5.4. Market size and forecast, by Stakeholders
    • 7.3.5.6. Rest of Europe
    • 7.3.5.6.1. Key market trends, growth factors and opportunities
    • 7.3.5.6.2. Market size and forecast, by Type
    • 7.3.5.6.3. Market size and forecast, by Application
    • 7.3.5.6.4. Market size and forecast, by Stakeholders
• 7.4. Asia-Pacific
  • 7.4.1. Key trends and opportunities
  • 7.4.2. Market size and forecast, by Type
  • 7.4.3. Market size and forecast, by Application
  • 7.4.4. Market size and forecast, by Stakeholders
  • 7.4.5. Market size and forecast, by country
    • 7.4.5.1. Japan
    • 7.4.5.1.1. Key market trends, growth factors and opportunities
    • 7.4.5.1.2. Market size and forecast, by Type
    • 7.4.5.1.3. Market size and forecast, by Application
    • 7.4.5.1.4. Market size and forecast, by Stakeholders
    • 7.4.5.2. China
    • 7.4.5.2.1. Key market trends, growth factors and opportunities
    • 7.4.5.2.2. Market size and forecast, by Type
    • 7.4.5.2.3. Market size and forecast, by Application
    • 7.4.5.2.4. Market size and forecast, by Stakeholders
    • 7.4.5.3. Australia
    • 7.4.5.3.1. Key market trends, growth factors and opportunities
    • 7.4.5.3.2. Market size and forecast, by Type
    • 7.4.5.3.3. Market size and forecast, by Application
    • 7.4.5.3.4. Market size and forecast, by Stakeholders
    • 7.4.5.4. India
    • 7.4.5.4.1. Key market trends, growth factors and opportunities
    • 7.4.5.4.2. Market size and forecast, by Type
    • 7.4.5.4.3. Market size and forecast, by Application
    • 7.4.5.4.4. Market size and forecast, by Stakeholders
    • 7.4.5.5. South Korea
    • 7.4.5.5.1. Key market trends, growth factors and opportunities
    • 7.4.5.5.2. Market size and forecast, by Type
    • 7.4.5.5.3. Market size and forecast, by Application
    • 7.4.5.5.4. Market size and forecast, by Stakeholders
    • 7.4.5.6. Rest of Asia-Pacific
    • 7.4.5.6.1. Key market trends, growth factors and opportunities
    • 7.4.5.6.2. Market size and forecast, by Type
    • 7.4.5.6.3. Market size and forecast, by Application
    • 7.4.5.6.4. Market size and forecast, by Stakeholders
• 7.5. LAMEA
  • 7.5.1. Key trends and opportunities
  • 7.5.2. Market size and forecast, by Type
  • 7.5.3. Market size and forecast, by Application
  • 7.5.4. Market size and forecast, by Stakeholders
  • 7.5.5. Market size and forecast, by country
    • 7.5.5.1. Brazil
    • 7.5.5.1.1. Key market trends, growth factors and opportunities
    • 7.5.5.1.2. Market size and forecast, by Type
    • 7.5.5.1.3. Market size and forecast, by Application
    • 7.5.5.1.4. Market size and forecast, by Stakeholders
    • 7.5.5.2. Saudi Arabia
    • 7.5.5.2.1. Key market trends, growth factors and opportunities
    • 7.5.5.2.2. Market size and forecast, by Type
    • 7.5.5.2.3. Market size and forecast, by Application
    • 7.5.5.2.4. Market size and forecast, by Stakeholders
    • 7.5.5.3. South Africa
    • 7.5.5.3.1. Key market trends, growth factors and opportunities
    • 7.5.5.3.2. Market size and forecast, by Type
    • 7.5.5.3.3. Market size and forecast, by Application
    • 7.5.5.3.4. Market size and forecast, by Stakeholders
    • 7.5.5.4. Rest of LAMEA
    • 7.5.5.4.1. Key market trends, growth factors and opportunities
    • 7.5.5.4.2. Market size and forecast, by Type
    • 7.5.5.4.3. Market size and forecast, by Application
    • 7.5.5.4.4. Market size and forecast, by Stakeholders

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top winning strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

• 9.1. Boston Scientific Corporation
  • 9.1.1. Company overview
  • 9.1.2. Key Executives
  • 9.1.3. Company snapshot
  • 9.1.4. Operating business segments
  • 9.1.5. Product portfolio
  • 9.1.6. Business performance
  • 9.1.7. Key strategic moves and developments
• 9.2. DexCom, Inc.
  • 9.2.1. Company overview
  • 9.2.2. Key Executives
  • 9.2.3. Company snapshot
  • 9.2.4. Operating business segments
  • 9.2.5. Product portfolio
  • 9.2.6. Business performance
  • 9.2.7. Key strategic moves and developments
• 9.3. Fitbit
  • 9.3.1. Company overview
  • 9.3.2. Key Executives
  • 9.3.3. Company snapshot
  • 9.3.4. Operating business segments
  • 9.3.5. Product portfolio
• 9.4. Koninklijke Philips N.V.
  • 9.4.1. Company overview
  • 9.4.2. Key Executives
  • 9.4.3. Company snapshot
  • 9.4.4. Operating business segments
  • 9.4.5. Product portfolio
  • 9.4.6. Business performance
  • 9.4.7. Key strategic moves and developments
• 9.5. Medtronic plc
  • 9.5.1. Company overview
  • 9.5.2. Key Executives
  • 9.5.3. Company snapshot
  • 9.5.4. Operating business segments
  • 9.5.5. Product portfolio
  • 9.5.6. Business performance
  • 9.5.7. Key strategic moves and developments
• 9.6. Omada Health
  • 9.6.1. Company overview
  • 9.6.2. Key Executives
  • 9.6.3. Company snapshot
  • 9.6.4. Operating business segments
  • 9.6.5. Product portfolio
  • 9.6.6. Key strategic moves and developments
• 9.7. Omron Corporation.
  • 9.7.1. Company overview
  • 9.7.2. Key Executives
  • 9.7.3. Company snapshot
  • 9.7.4. Operating business segments
  • 9.7.5. Product portfolio
  • 9.7.6. Business performance
  • 9.7.7. Key strategic moves and developments
• 9.8. SAMSUNG ELECTRONICS CO., LTD.
  • 9.8.1. Company overview
  • 9.8.2. Key Executives
  • 9.8.3. Company snapshot
  • 9.8.4. Operating business segments
  • 9.8.5. Product portfolio
  • 9.8.6. Business performance
• 9.9. Welldoc, Inc
  • 9.9.1. Company overview
  • 9.9.2. Key Executives
  • 9.9.3. Company snapshot
  • 9.9.4. Operating business segments
  • 9.9.5. Product portfolio
  • 9.9.6. Key strategic moves and developments
• 9.10. Teladoc Health, Inc.
  • 9.10.1. Company overview
  • 9.10.2. Key Executives
  • 9.10.3. Company snapshot
  • 9.10.4. Operating business segments
  • 9.10.5. Product portfolio
  • 9.10.6. Business performance
  • 9.10.7. Key strategic moves and developments